{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:27:45Z","timestamp":1769052465798,"version":"3.49.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1757-2215-7-23","type":"journal-article","created":{"date-parts":[[2014,2,15]],"date-time":"2014-02-15T18:01:46Z","timestamp":1392487306000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The MOC31PE immunotoxin reduces cell migration and induces gene expression and cell death in ovarian cancer cells"],"prefix":"10.1186","volume":"7","author":[{"given":"Merete Thune","family":"Wiiger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemaseh","family":"Bideli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d8ystein","family":"Fodstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kjersti","family":"Flatmark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,2,15]]},"reference":[{"key":"236_CR1","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al.: Phase III trial of carboplatin and paclitaxel compared With cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a gynecologic oncology group study. J Clin Oncol 2003, 21: 3194\u20133200. 10.1200\/JCO.2003.02.153","journal-title":"J Clin Oncol"},{"key":"236_CR2","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.critrevonc.2012.04.002","volume":"84","author":"A Bamias","year":"2012","unstructured":"Bamias A, Pignata S, Pujade-Lauraine E: Angiogenesis: a promising therapeutic target for ovarian cancer. Crit Rev Oncol\/Hematol 2012, 84: 314\u2013326. 10.1016\/j.critrevonc.2012.04.002","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"236_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ctrv.2011.04.002","volume":"38","author":"C Patriarca","year":"2011","unstructured":"Patriarca C, Macchi RM, Marschner AK, Mellstedt H: Epithelial cell adhesion molecule expression (CD326) in cancer: a short review. Cancer Treat Rev 2011, 38: 68\u201375.","journal-title":"Cancer Treat Rev"},{"key":"236_CR4","doi-asserted-by":"publisher","first-page":"R75","DOI":"10.1186\/bcr2922","volume":"13","author":"S Tveito","year":"2011","unstructured":"Tveito S, Andersen K, Karesen R, Fodstad O: Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles. Breast Cancer Res 2011, 13: R75. 10.1186\/bcr2922","journal-title":"Breast Cancer Res"},{"key":"236_CR5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1371\/journal.pmed.0050232","volume":"5","author":"M K\u00f6bel","year":"2008","unstructured":"K\u00f6bel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, et al.: Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med 2008, 5: 1749\u20131759.","journal-title":"PLoS Med"},{"key":"236_CR6","doi-asserted-by":"publisher","first-page":"e17617","DOI":"10.1371\/journal.pone.0017617","volume":"6","author":"C Emmanuel","year":"2011","unstructured":"Emmanuel C, Gava N, Kennedy C, Balleine RL, Sharma R, Wain G, et al.: Comparison of expression profiles in ovarian epithelium In Vivo and ovarian cancer identifies novel candidate genes involved in disease pathogenesis. PLoS ONE 2011, 6: e17617. 10.1371\/journal.pone.0017617","journal-title":"PLoS ONE"},{"key":"236_CR7","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1097\/CJI.0b013e3181c54991","volume":"33","author":"K Risberg","year":"2010","unstructured":"Risberg K, Fodstad \u00d8, Andersson Y: Anti-melanoma activity of the 9.2.27PE immunotoxin in dacarbazine resistant cells. J Immunother 2010, 33: 272\u2013278. 10.1097\/CJI.0b013e3181c54991","journal-title":"J Immunother"},{"key":"236_CR8","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/sj.bjc.6605312","volume":"101","author":"Y Andersson","year":"2009","unstructured":"Andersson Y, Engebraaten O, Fodstad O: Synergistic anti-cancer effects of immunotoxin and cyclosporin in vitro and in vivo. Br J Cancer 2009, 101: 1307\u20131315. 10.1038\/sj.bjc.6605312","journal-title":"Br J Cancer"},{"key":"236_CR9","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.athoracsur.2003.07.006","volume":"77","author":"M Xavier","year":"2004","unstructured":"Xavier M: Drug immunosuppression therapy for adult heart transplantation. Part 1: immune response to allograft and mechanism of action of immunosuppressants. Ann Thorac Surg 2004, 77: 354\u2013362. 10.1016\/j.athoracsur.2003.07.006","journal-title":"Ann Thorac Surg"},{"key":"236_CR10","first-page":"RA221","volume":"15","author":"S Obchoei","year":"2009","unstructured":"Obchoei S, Wongkhan S, Wongkham C, Li M, Yao Q, Chen C: Cyclophilin A: potential functions and therapeuti target for human cancer. Med Sci Monit 2009, 15: RA221-RA232.","journal-title":"Med Sci Monit"},{"key":"236_CR11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/j.1525-1438.2007.00787.x","volume":"17","author":"RJJ Morgan","year":"2007","unstructured":"Morgan RJJ, Synold T, Gandara D, Muggia F, Scudder S, Reed E, et al.: Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California cancer consortium trial. Int J Gynecol Cancer 2007, 17: 373\u2013378. 10.1111\/j.1525-1438.2007.00787.x","journal-title":"Int J Gynecol Cancer"},{"key":"236_CR12","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/sj.neo.7900019","volume":"1","author":"A Sood","year":"1999","unstructured":"Sood A, Sorosky J, Squatrito R, Skilling J, Anderson B, Buller R: Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies. Neoplasia 1999, 1: 118\u2013122. 10.1038\/sj.neo.7900019","journal-title":"Neoplasia"},{"key":"236_CR13","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1002\/(SICI)1097-0215(19960917)67:6<826::AID-IJC12>3.0.CO;2-#","volume":"67","author":"C Marth","year":"1996","unstructured":"Marth C, Zeimet AG, Herold M, Brumm C, Windbichler G, M\u00fcller-Holzner E, et al.: Different effects of interferons, interleukin-1\u03b2 and tumor necrosis factor-\u03b1 in normal (OSE) and malignant human ovarian epithelial cells. Int J Cancer 1996, 67: 826\u2013830. 10.1002\/(SICI)1097-0215(19960917)67:6<826::AID-IJC12>3.0.CO;2-#","journal-title":"Int J Cancer"},{"key":"236_CR14","first-page":"3668","volume":"45","author":"RN Buick","year":"1985","unstructured":"Buick RN, Pullano R, Trent JM: Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985, 45: 3668\u20133676.","journal-title":"Cancer Res"},{"key":"236_CR15","first-page":"49","volume":"63","author":"AT Myklebust","year":"1991","unstructured":"Myklebust AT, Beiske K, Pharo A, Davies CL, Aamdahl S, Fodstad \u00d8: Selection of anti-SCLC antibodies for diagnosis of bone marrow metastasis. Br J Cancer 1991, 63: 49\u201353.","journal-title":"Br J Cancer"},{"key":"236_CR16","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/1097-0215(20001215)88:6<970::AID-IJC21>3.0.CO;2-Q","volume":"88","author":"O Engebraaten","year":"2000","unstructured":"Engebraaten O, Sivam G, Juell S, Fodstad \u00d8: Systemic immunotoxin treatment inhibits formation of human breast cancer metastasis and tumor growth in nude rats. Int J Cancer 2000, 88: 970\u2013976. 10.1002\/1097-0215(20001215)88:6<970::AID-IJC21>3.0.CO;2-Q","journal-title":"Int J Cancer"},{"key":"236_CR17","first-page":"1050","volume":"5","author":"Y Andersson","year":"2006","unstructured":"Andersson Y, Le H, Juell S, Fodstad \u00d8: AMP-activated protein kinase protects against ant-epidermal growth factor recetor-pseudomonas exotoxin A immunotoxin-induced MA11breast cancer cell death. Mol Cancer Res 2006, 5: 1050\u20131059.","journal-title":"Mol Cancer Res"},{"key":"236_CR18","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrc3217","volume":"12","author":"EN Arwert","year":"2012","unstructured":"Arwert EN, Hoste E, Watt FM: Epithelial stem cells, wound healing and cancer. Nat Rev Cancer 2012, 12: 170\u2013180. 10.1038\/nrc3217","journal-title":"Nat Rev Cancer"},{"key":"236_CR19","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/CJI.0b013e31821e00ae","volume":"34","author":"K Risberg","year":"2011","unstructured":"Risberg K, Guldvik IJ, Palchaudhuri R, Xi Y, Fodstad \u00d8, Hergenrother PJ, et al.: Triphenylmethyl derivatived enhances the anticancer effect of immunotoxins. J Immunother 2011, 34: 438\u2013447. 10.1097\/CJI.0b013e31821e00ae","journal-title":"J Immunother"},{"key":"236_CR20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1200\/JCO.1997.15.5.1945","volume":"15","author":"S Chambers","year":"1997","unstructured":"Chambers S, Chambers J, Davis C, Kohorn E, Schwartz P, Lorber M, et al.: Pharmacokinetic and phase I trial of intraperitoneal carboplatin and cyclosporine in refractory ovarian cancer patients. J Clin Oncol 1997, 15: 1945\u20131952.","journal-title":"J Clin Oncol"},{"key":"236_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1752-0509-6-3","volume":"6","author":"R Ben-Hamo","year":"2012","unstructured":"Ben-Hamo R, Efroni S: Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies. BMC Syst Biol 2012, 6: 3. 10.1186\/1752-0509-6-3","journal-title":"BMC Syst Biol"},{"key":"236_CR22","doi-asserted-by":"publisher","first-page":"209","DOI":"10.4331\/wjbc.v1.i7.209","volume":"1","author":"H Itamochi","year":"2010","unstructured":"Itamochi H: Targeted therapies in epithelial ovarian cancer: molecular mechanism of action. World J Biol Chem 2010, 1: 209\u20132200. 10.4331\/wjbc.v1.i7.209","journal-title":"World J Biol Chem"},{"key":"236_CR23","doi-asserted-by":"publisher","first-page":"viii77","DOI":"10.1093\/annonc\/mdr531","volume":"22","author":"K Bell-McGuinn","year":"2011","unstructured":"Bell-McGuinn K, Konner J, Tew W, Spriggs DR: New drugs for ovarian cancer. Ann Oncol 2011, 22: viii77-viii82.","journal-title":"Ann Oncol"},{"key":"236_CR24","doi-asserted-by":"publisher","first-page":"6624","DOI":"10.1073\/pnas.87.17.6624","volume":"87","author":"DJ Good","year":"1990","unstructured":"Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, et al.: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci 1990, 87: 6624\u20136628. 10.1073\/pnas.87.17.6624","journal-title":"Proc Natl Acad Sci"},{"key":"236_CR25","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1007\/s00018-007-7486-z","volume":"65","author":"S Kazerounian","year":"2008","unstructured":"Kazerounian S, Yee KO, Lawler J: Thrombospondins in cancer. Cell Mol Life Sci 2008, 65: 700\u2013712. 10.1007\/s00018-007-7486-z","journal-title":"Cell Mol Life Sci"},{"key":"236_CR26","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1242\/dev.060996","volume":"138","author":"MD Combs","year":"2011","unstructured":"Combs MD, Braitsch CM, Lange AW, James JF, Yutzey KE: NFATC1 promotes epicardium-derived cell invasion into myocardium. Dev 2011, 138: 1747\u20131757. 10.1242\/dev.060996","journal-title":"Dev"},{"key":"236_CR27","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0161-5890(03)00169-X","volume":"40","author":"AD Cristillo","year":"2003","unstructured":"Cristillo AD, Bierer BE: Regulation of CXCR4 expression in human T lymphocytes by calcium and calcineurin. Mol Immunol 2003, 40: 539\u2013553. 10.1016\/S0161-5890(03)00169-X","journal-title":"Mol Immunol"},{"key":"236_CR28","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.ejca.2007.03.004","volume":"43","author":"K Hata","year":"2007","unstructured":"Hata K, Dhar DK, Watanabe Y, Nakai H, Hoshiai H: Expression of metastin and a G-protein-coupled receptor (AXOR12) in epithelial ovarian cancer. Eur J Cancer 2007, 43: 1452\u20131459. 10.1016\/j.ejca.2007.03.004","journal-title":"Eur J Cancer"},{"key":"236_CR29","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1038\/onc.2011.39","volume":"30","author":"T Jiffar","year":"2011","unstructured":"Jiffar T, Yilmaz T, Lee J, Hanna E, El-Naggar A, Yu D, et al.: KiSS1 mediates platinum sensitivity and metastasis suppression in head and neck squamous cell carcinoma. Oncogene 2011, 30: 3163\u20133173. 10.1038\/onc.2011.39","journal-title":"Oncogene"},{"key":"236_CR30","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1210\/me.2010-0015","volume":"24","author":"MA Pearen","year":"2010","unstructured":"Pearen MA, Muscat GEO: Minireview: nuclear hormone receptor 4A signaling: implications for metabolic disease. Mol Endocrinol 2010, 24: 1891\u20131903. 10.1210\/me.2010-0015","journal-title":"Mol Endocrinol"},{"key":"236_CR31","doi-asserted-by":"publisher","first-page":"4725","DOI":"10.1038\/sj.onc.1209601","volume":"25","author":"U Moll","year":"2006","unstructured":"Moll U, Marchenko M, Zhang X: p53 and Nurr77\/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene 2006, 25: 4725\u20134743. 10.1038\/sj.onc.1209601","journal-title":"Oncogene"},{"key":"236_CR32","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1038\/nm1579","volume":"13","author":"S Mullican","year":"2007","unstructured":"Mullican S, Zhang S, Konopleva M, Ruvolo V, Andreeff M, Milbrandt J, et al.: Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 2007, 13: 730\u2013735. 10.1038\/nm1579","journal-title":"Nat Med"},{"key":"236_CR33","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1002\/eji.200940231","volume":"40","author":"J Thompson","year":"2010","unstructured":"Thompson J, Burger ML, Whang H, Winoto A: Protein kinase C regulates mitochondrial targeting of Nur77 and its family member Nor-1 in thymocytes undergoing apoptosis. Eur J Immunol 2010, 40: 2041\u20132049. 10.1002\/eji.200940231","journal-title":"Eur J Immunol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1757-2215-7-23.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:08:47Z","timestamp":1630552127000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/1757-2215-7-23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,15]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["236"],"URL":"https:\/\/doi.org\/10.1186\/1757-2215-7-23","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,15]]},"assertion":[{"value":"25 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}